Xiao-Gao Liu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xiao-Gao Liu

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

ACS Medicinal Chemistry Letters|March 19, 2021

Novel Potent Selective Orally Active S1P5 Receptor AntagonistsBin Ma, Kevin M Guckian, Xiao-Gao Liu, et al.

Bioorganic & Medicinal Chemistry Letters|January 27, 2004

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituentUday R Khire, Donald Bankston, James Barbosa, et al.

Journal of Medicinal Chemistry|September 25, 2007

Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

ACS Medicinal Chemistry Letters|March 19, 2021

Novel Potent Selective Orally Active S1P5 Receptor AntagonistsBin Ma, Kevin M Guckian, Xiao-Gao Liu, et al.

Bioorganic & Medicinal Chemistry Letters|January 27, 2004

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituentUday R Khire, Donald Bankston, James Barbosa, et al.

Journal of Medicinal Chemistry|September 25, 2007

Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.

Pageof 1